Neoadjuvant chemotherapy with gemcitabine-based regimens improves the prognosis of node positive resectable pancreatic head cancer

The effectiveness of preoperative (neoadjuvant) chemotherapy (NAC) for resectable pancreatic ductal adenocarcinoma (PDAC) remains unclear. The present study retrospectively evaluated the efficacy of NAC with gemcitabine (GEM)-based regimens or GEM monotherapy for resectable PDAC. Between 2006 and 20...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Clin Oncol
Autors principals: Tajima, Hidehiro, Ohta, Tetsuo, Okazaki, Mitsuyoshi, Yamaguchi, Takahisa, Ohbatake, Yoshinao, Okamoto, Koichi, Nakanuma, Shinichi, Kinoshita, Jun, Makino, Isamu, Nakamura, Keishi, Miyashita, Tomoharu, Takamura, Hiroyuki, Ninomiya, Itasu, Fushida, Sachio, Nakamura, Hiroyuki
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2019
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587007/
https://ncbi.nlm.nih.gov/pubmed/31281650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1867
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars